Cargando…

Peptide Nanoparticle-Mediated Combinatorial Delivery of Cancer-Related siRNAs for Synergistic Anti-Proliferative Activity in Triple Negative Breast Cancer Cells

Triple negative breast cancer (TNBC) is one of the deadliest types of cancer for women of different age groups. Frequently this cancer does not respond to conservative treatment. Combinatorial RNAi can be suggested as an advanced approach to TNBC therapy. Due to the fact that TNBC cells overexpress...

Descripción completa

Detalles Bibliográficos
Autores principales:	Egorova, Anna, Pyankov, Ivan, Maretina, Marianna, Baranov, Vladislav, Kiselev, Anton
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540820/ https://www.ncbi.nlm.nih.gov/pubmed/34681181 http://dx.doi.org/10.3390/ph14100957

Ejemplares similares

Synergistic Anti-Angiogenic Effects Using Peptide-Based Combinatorial Delivery of siRNAs Targeting VEGFA, VEGFR1, and Endoglin Genes
por: Egorova, Anna A., et al.
Publicado: (2019)

Magnetic Nanoparticles as a Component of Peptide-Based DNA Delivery System for Suicide Gene Therapy of Uterine Leiomyoma
por: Shtykalova, Sofia, et al.
Publicado: (2022)

Characterization of iRGD-Ligand Modified Arginine-Histidine-Rich Peptides for Nucleic Acid Therapeutics Delivery to αvβ3 Integrin-Expressing Cancer Cells
por: Egorova, Anna, et al.
Publicado: (2020)

Evaluation of Mean Percentage of Full-Length SMN Transcripts as a Molecular Biomarker of Spinal Muscular Atrophy
por: Maretina, Marianna, et al.
Publicado: (2022)

iRGD-Targeted Peptide Nanoparticles for Anti-Angiogenic RNAi-Based Therapy of Endometriosis
por: Egorova, Anna, et al.
Publicado: (2023)

Development of iRGD-Modified Peptide Carriers for Suicide Gene Therapy of Uterine Leiomyoma
por: Egorova, Anna, et al.
Publicado: (2021)

Peptide-Based Nanoparticles for αvβ3 Integrin-Targeted DNA Delivery to Cancer and Uterine Leiomyoma Cells
por: Egorova, Anna, et al.
Publicado: (2022)

Polycondensed Peptide Carriers Modified with Cyclic RGD Ligand for Targeted Suicide Gene Delivery to Uterine Fibroid Cells
por: Egorova, Anna, et al.
Publicado: (2022)

Molecular Factors Involved in Spinal Muscular Atrophy Pathways as Possible Disease-modifying Candidates
por: Maretina, Marianna A., et al.
Publicado: (2018)

Characterization of modified mesoporous silica nanoparticles as vectors for siRNA delivery
por: Slita, Anna, et al.
Publicado: (2018)

Development of 2′-O-Methyl and LNA Antisense Oligonucleotides for SMN2 Splicing Correction in SMA Cells
por: Maretina, Marianna, et al.
Publicado: (2023)

Strategies for Delivery of siRNAs to Ovarian Cancer Cells
por: Farra, Rossella, et al.
Publicado: (2019)

Quick synthesis of a novel combinatorial delivery system of siRNA and doxorubicin for a synergistic anticancer effect
por: Chen, Mengchun, et al.
Publicado: (2019)

AGO-accessible anticancer siRNAs designed with synergistic miRNA-like activity
por: Gu, Dowoon, et al.
Publicado: (2021)

Where should siRNAs go: applicable organs for siRNA drugs
por: Ahn, Insook, et al.
Publicado: (2023)

Efficacy Analysis of Combinatorial siRNAs against HIV Derived from One Double Hairpin RNA Precursor
por: Liu, Chang, et al.
Publicado: (2017)

Enhanced Cancer Theranostics with Self-Assembled, Multilabeled siRNAs
por: Kozuch, Stephen D., et al.
Publicado: (2018)

Therapeutic Potency of Nanoformulations of siRNAs and shRNAs in Animal Models of Cancers
por: Karim, Md. Emranul, et al.
Publicado: (2018)

Kinetics and synergistic effects of siRNAs targeting structural and replicase genes of SARS‐associated coronavirus
por: He, Ming-Liang, et al.
Publicado: (2006)

Knocking down Disease with siRNAs
por: Dykxhoorn, Derek M., et al.
Publicado: (2006)

Identification of ta-siRNAs and Cis-nat-siRNAs in Cassava and Their Roles in Response to Cassava Bacterial Blight
por: Quintero, Andrés, et al.
Publicado: (2013)

Advances in siRNA therapeutics and synergistic effect on siRNA activity using emerging dual ribose modifications
por: Gangopadhyay, Sumit, et al.
Publicado: (2022)

Utility of MicroRNAs and siRNAs in Cervical Carcinogenesis
por: Díaz-González, Sacnite del Mar, et al.
Publicado: (2015)

The roles of microRNAs and siRNAs in mammalian spermatogenesis
por: Hilz, Stephanie, et al.
Publicado: (2016)

Genome-wide screens for effective siRNAs through assessing the size of siRNA effects
por: Zhang, Xiaohua Douglas
Publicado: (2008)

Small interfering RNAs (siRNAs) in cancer therapy: a nano-based approach
por: Mahmoodi Chalbatani, Ghanbar, et al.
Publicado: (2019)

Methylation Levels of SLC23A2 and NCOR2 Genes Correlate with Spinal Muscular Atrophy Severity
por: Zheleznyakova, Galina Yu., et al.
Publicado: (2015)

Structural and Functional Analysis of Viral siRNAs
por: Szittya, Gyorgy, et al.
Publicado: (2010)

Progress towards in Vivo Use of siRNAs
por: Behlke, Mark A.
Publicado: (2006)

The master role of siRNAs in plant immunity
por: Kong, Xiuzhen, et al.
Publicado: (2022)

Anti-EGF Receptor Aptamer-Guided Co-Delivery of Anti-Cancer siRNAs and Quantum Dots for Theranostics of Triple-Negative Breast Cancer
por: Kim, Min Woo, et al.
Publicado: (2019)

Non-Covalent Associates of siRNAs and AuNPs Enveloped with Lipid Layer and Doped with Amphiphilic Peptide for Efficient siRNA Delivery
por: Poletaeva, Julia, et al.
Publicado: (2018)

Releasing the Immune System Brakes Using siRNAs Enhances Cancer Immunotherapy
por: Sioud, Mouldy
Publicado: (2019)

Cancer therapeutic targeting using mutant–p53-specific siRNAs
por: Ubby, Ifeoma, et al.
Publicado: (2019)

BmNPV p35 Reduces the Accumulation of Virus-Derived siRNAs and Hinders the Function of siRNAs to Facilitate Viral Infection
por: Zhao, Shudi, et al.
Publicado: (2022)

Synergistic anti-proliferative activity of JQ1 and GSK2801 in triple-negative breast cancer
por: Yellapu, Nanda Kumar, et al.
Publicado: (2022)

Synergistic treatment of osteosarcoma with biomimetic nanoparticles transporting doxorubicin and siRNA
por: Zhao, Jingtong, et al.
Publicado: (2023)

Learning signaling networks from combinatorial perturbations by exploiting siRNA off-target effects
por: Tiuryn, Jerzy, et al.
Publicado: (2019)

Cell-specific RNA interference by peptide-inhibited-peptidase-activated siRNAs
por: Koehn, Sandra, et al.
Publicado: (2010)

Genome-Wide Profiling and Analysis of Arabidopsis siRNAs
por: Kasschau, Kristin D, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_mjhmagbt380o70nfo29cp21bfv